New Faculty

Dr. Mark Huffman joins the Department of Medicine

Mark Huffman, MD
Mark Huffman, MD

In January 2022, Dr. Mark Huffman will join the Washington University School of Medicine as Professor of Medicine and Co-Director of the Global Health Center. He also has a secondary appointment at the George Institute for Global Health at the University of New South Wales and has previously served as the inaugural director of the Center for Global Cardiovascular Health and Quentin D. Young Professor of Health Policy at Northwestern University.

Dr. Huffman is a practicing cardiologist with interest and experience in complex preventive cardiology, lipidology, and hypertension care. He has experience in cardiovascular epidemiology, clinical trials, implementation research, and health systems and policy research that aligns with the World Health Organization’s Best Buys for the Prevention and Control of Noncommunicable Diseases toward achieving the United Nations’ Sustainable Development Goals. He has maintained active NIH grant support since 2009, including serving as PI or mPI on the NHLBI-supported clinical trials in India (K99/R00HL107749), Nigeria (R01HL144708, UG3HL152381), and Chicago (R33HL139852, UG3HL154297). He also serves as mPI on cardiovascular research training grant in Nigeria (D43TW011976), demonstrating my commitment to research training and capacity building. He has served as the senior program advisor for the World Heart Federation’s Emerging Leaders program, which has trained nearly 150 early-to-mid-career professionals from >50 countries over the past 7 years in implementation research, health systems, and health policy research.

Dr. Huffman has experience teaching and directing medical and graduate school courses at the intersection of health and society, including cardiovascular disease epidemiology, systematic reviews, and essential medicines. He is an active research mentor, and his mentees have received awards from the Fogarty global health fellows’ program (7 awards), Fogarty global health leader (1 K43 award), US State Department (Fulbright), NHLBI (1 K23, F32, and F31 award each; K99 award notice of award pending), among other sources. Key clinical interests are reventive cardiology, lipidology, hypertension management Research areas are global cardiovascular implementation science, health system, and policy research, including related to World Health Organization Best Buys for the Prevention and Control of Noncommunicable Diseases, to improve cardiovascular health and health care toward achieving to the United Nations’ Sustainable Development Goals.